MeiraGTx Holdings PLC (NASDAQ:MGTX) Shares Sold by Privium Fund Management B.V.

Key Points

• Privium Fund Management B.V. reduced its stake in MeiraGTx Holdings PLC by 48.0%, selling 108,078 shares and owning 117,000 shares by the end of the quarter.
• Several hedge funds increased their investments in MeiraGTx during the same period, with Readystate Asset Management LP and CWM LLC experiencing significant gains in share ownership.
• MeiraGTx reported a loss of ($0.51) EPS for the last quarter, missing analyst estimates, as its revenue fell short at $1.93 million compared to expectations of $4.44 million.

Privium Fund Management B.V. lessened its stake in shares of MeiraGTx Holdings PLC (NASDAQ:MGTX - Free Report) by 48.0% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 117,000 shares of the company's stock after selling 108,078 shares during the period. Privium Fund Management B.V. owned about 0.15% of MeiraGTx worth $793,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Wellington Management Group LLP grew its position in shares of MeiraGTx by 0.9% during the 4th quarter. Wellington Management Group LLP now owns 151,126 shares of the company's stock worth $920,000 after buying an additional 1,379 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in MeiraGTx by 68.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 4,975 shares of the company's stock worth $30,000 after buying an additional 2,016 shares during the period. Corebridge Financial Inc. grew its stake in MeiraGTx by 11.6% in the fourth quarter. Corebridge Financial Inc. now owns 23,147 shares of the company's stock valued at $141,000 after purchasing an additional 2,405 shares during the last quarter. Summit Investment Advisors Inc. raised its stake in shares of MeiraGTx by 106.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 4,871 shares of the company's stock worth $30,000 after acquiring an additional 2,515 shares in the last quarter. Finally, Rhumbline Advisers lifted its position in MeiraGTx by 6.1% during the first quarter. Rhumbline Advisers now owns 58,227 shares of the company's stock valued at $395,000 after acquiring an additional 3,336 shares during the last quarter. Hedge funds and other institutional investors own 67.48% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on MGTX shares. Wall Street Zen raised shares of MeiraGTx from a "sell" rating to a "hold" rating in a report on Saturday, July 5th. Chardan Capital cut their price objective on shares of MeiraGTx from $38.00 to $35.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th.

MeiraGTx Stock Performance

MeiraGTx stock traded up $0.19 during trading hours on Monday, hitting $7.84. 414,190 shares of the stock traded hands, compared to its average volume of 691,273. MeiraGTx Holdings PLC has a 1 year low of $3.85 and a 1 year high of $8.98. The stock has a market capitalization of $630.02 million, a price-to-earnings ratio of -3.38 and a beta of 1.25. The company has a debt-to-equity ratio of 2.34, a current ratio of 1.53 and a quick ratio of 1.51. The firm's 50 day moving average price is $7.06 and its 200-day moving average price is $6.60.

MeiraGTx (NASDAQ:MGTX - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.13). MeiraGTx had a negative return on equity of 241.05% and a negative net margin of 484.90%. The company had revenue of $1.93 million for the quarter, compared to analyst estimates of $4.44 million. As a group, equities analysts expect that MeiraGTx Holdings PLC will post -1.48 EPS for the current fiscal year.

Insider Buying and Selling at MeiraGTx

In other MeiraGTx news, CEO Alexandria Forbes sold 47,500 shares of MeiraGTx stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $7.97, for a total transaction of $378,575.00. Following the sale, the chief executive officer owned 1,361,483 shares of the company's stock, valued at $10,851,019.51. The trade was a 3.37% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Richard Giroux sold 24,000 shares of the stock in a transaction dated Tuesday, July 22nd. The shares were sold at an average price of $8.52, for a total transaction of $204,480.00. Following the completion of the sale, the chief financial officer owned 853,494 shares of the company's stock, valued at approximately $7,271,768.88. The trade was a 2.74% decrease in their position. The disclosure for this sale can be found here. 7.50% of the stock is currently owned by insiders.

MeiraGTx Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.